Search

Your search keyword '"Snel MF"' showing total 57 results

Search Constraints

Start Over You searched for: Author "Snel MF" Remove constraint Author: "Snel MF"
57 results on '"Snel MF"'

Search Results

1. The role of oxidised self-lipids and alveolar macrophage CD1b expression in COPD

2. Developing a multivariable prediction model for functional outcome after reperfusion therapy for acute ischaemic stroke: study protocol for the Targeting Optimal Thrombolysis Outcomes (TOTO) multicentre cohort study

3. Developing a multivariable prediction model for functional outcome after reperfusion therapy for acute ischaemic stroke: study protocol for the Targeting Optimal Thrombolysis Outcomes (TOTO) multicentre cohort study

4. Exploring Top-Down Mass Spectrometric Approaches To Probe Forest Cobra ( Naja melanoleuca ) Venom Proteoforms.

5. Photobiomodulation in the infrared spectrum reverses the expansion of circulating natural killer cells and brain microglial activation in Sanfilippo mice.

6. Evaluation of neuroretina following i.v. or intra-CSF AAV9 gene replacement in mice with MPS IIIA, a childhood dementia.

7. Drosophila melanogaster models of MPS IIIC (Hgsnat-deficiency) highlight the role of glia in disease presentation.

8. Spatial MS multiomics on clinical prostate cancer tissues.

9. Compromised transcription-mRNA export factor THOC2 causes R-loop accumulation, DNA damage and adverse neurodevelopment.

10. Characterisation of the forest cobra (Naja melanoleuca) venom using a multifaceted mass spectrometric-based approach.

11. Repetitive, non-invasive imaging of neurodegeneration, and prevention of it with gene replacement, in mice with Sanfilippo syndrome.

12. Filipin complex-reactive brain lesions: a cautionary tale.

13. Biomarkers for predicting disease course in Sanfilippo syndrome: An urgent unmet need in childhood-onset dementia.

14. Colchicine exerts anti-atherosclerotic and -plaque-stabilizing effects targeting foam cell formation.

15. FAST-IT: F ind A S imple T est - I n T IA (transient ischaemic attack): a prospective cohort study to develop a multivariable prediction model for diagnosis of TIA through proteomic discovery and candidate lipid mass spectrometry, neuroimaging and machine learning-study protocol.

16. Unravelling Prostate Cancer Heterogeneity Using Spatial Approaches to Lipidomics and Transcriptomics.

17. Equivalent Carbon Number and Interclass Retention Time Conversion Enhance Lipid Identification in Untargeted Clinical Lipidomics.

18. MUCOPOLYSACCHARIDOSIS II (MPS II) IN A FREE-LIVING KAKA (NESTOR MERIDIONALIS) IN NEW ZEALAND.

19. Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition.

20. To Make or Take: Bacterial Lipid Homeostasis during Infection.

21. Is SGSH heterozygosity a risk factor for early-onset neurodegenerative disease?

22. Increased Alveolar Heparan Sulphate and Reduced Pulmonary Surfactant Amount and Function in the Mucopolysaccharidosis IIIA Mouse.

23. Removal of optimal cutting temperature (O.C.T.) compound from embedded tissue for MALDI imaging of lipids.

24. The role of oxidised self-lipids and alveolar macrophage CD1b expression in COPD.

25. Reciprocal signaling between mTORC1 and MNK2 controls cell growth and oncogenesis.

26. Is the eye a window to the brain in Sanfilippo syndrome?

27. AAVrh10 Vector Corrects Disease Pathology in MPS IIIA Mice and Achieves Widespread Distribution of SGSH in Large Animal Brains.

28. Early disease course is unaltered in mucopolysaccharidosis type IIIA (MPS IIIA) mice lacking α-synuclein.

29. Evaluation of Small Molecule Drug Uptake in Patient-Derived Prostate Cancer Explants by Mass Spectrometry.

30. Synthetic Disaccharide Standards Enable Quantitative Analysis of Stored Heparan Sulfate in MPS IIIA Murine Brain Regions.

31. Evaluation of Disease Lesions in the Developing Canine MPS IIIA Brain.

32. Synthesis and mass spectrometric analysis of disaccharides from methanolysis of heparan sulfate.

33. Lysosomal N-acetyltransferase interacts with ALIX and is detected in extracellular vesicles.

34. Eukaryotic elongation factor 2 kinase upregulates the expression of proteins implicated in cell migration and cancer cell metastasis.

35. Neuronal-specific impairment of heparan sulfate degradation in Drosophila reveals pathogenic mechanisms for Mucopolysaccharidosis type IIIA.

36. A novel conditional Sgsh knockout mouse model recapitulates phenotypic and neuropathic deficits of Sanfilippo syndrome.

37. Slow, continuous enzyme replacement via spinal CSF in dogs with the paediatric-onset neurodegenerative disease, MPS IIIA.

38. Inbred Mouse Populations Exhibit Intergenerational Changes in Intestinal Microbiota Composition and Function Following Introduction to a Facility.

39. Small molecule MALDI MS imaging: Current technologies and future challenges.

40. Low-dose, continuous enzyme replacement therapy ameliorates brain pathology in the neurodegenerative lysosomal disorder mucopolysaccharidosis type IIIA.

41. Low-dose, continual enzyme delivery ameliorates some aspects of established brain disease in a mouse model of a childhood-onset neurodegenerative disorder.

42. Butanolysis derivatization: improved sensitivity in LC-MS/MS quantitation of heparan sulfate in urine from mucopolysaccharidosis patients.

43. Determination of the role of injection site on the efficacy of intra-CSF enzyme replacement therapy in MPS IIIA mice.

44. Evaluation of enzyme dose and dose-frequency in ameliorating substrate accumulation in MPS IIIA Huntaway dog brain.

45. Delivery of therapeutic protein for prevention of neurodegenerative changes: comparison of different CSF-delivery methods.

46. Disease stage determines the efficacy of treatment of a paediatric neurodegenerative disease.

47. A simple method for early age phenotype confirmation using toe tissue from a mouse model of MPS IIIA.

48. High-spatial resolution matrix-assisted laser desorption ionization imaging analysis of glucosylceramide in spleen sections from a mouse model of Gaucher disease.

49. Novel molecular tumour classification using MALDI-mass spectrometry imaging of tissue micro-array.

50. MALDI-ion mobility separation-mass spectrometry imaging of glucose-regulated protein 78 kDa (Grp78) in human formalin-fixed, paraffin-embedded pancreatic adenocarcinoma tissue sections.

Catalog

Books, media, physical & digital resources